Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03168178Phase 4Withdrawn
Phase 4, randomised, open-label trial in intraamniotic infection (IAI) and chorioamnionitis (IAI) (2 arms), sponsored by University of Utah. Primary endpoint: Neonatal antibiotic treatment as recommended by the EONS calculator at 2 hours. Planned start Jun 2017; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03168178.